Search results
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 1 day agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
ClickOnDetroit· 5 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Barbra Streisand explains Melissa McCarthy Ozempic comment: 'Forgot the world is reading'
USA TODAY via Yahoo News· 24 minutes agoIn June 2021, the Food and Drug Administration approved the semaglutide – under the brand name...
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds
Prevention· 4 days agoBased on recent findings, Eli Lilly plans to submit the material to the U.S. Food and Drug ...
Barbra Streisand publicly asks Melissa McCarthy about Ozempic, sparking debate on weight and shaming
ABC News· 2 hours agoA comment Barbra Streisand left on an Instagram post shared by Melissa McCarthy has sparked a...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 5 days ago"As important as these drugs...potential to bankrupt Medicare, Medicaid and our entire health care...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 7 hours agoNow, Lilly is planning to ask the Food and Drug Administration to sign off on tirzepatide as a sleep...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 1 day agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 13 hours agoDive Insight: The obesity drug boom has made Lilly the most valuable pharmaceutical company in the...